NBB Graduate Program Courses
The expectations, requirements, and recommendations for making satisfactory progress toward completion of the graduate program in Neurobiology and Behavior (NB&B) are summarized here. Most students will enter the NB&B program in their second year at UCI following a year in the gateway Interdepartmental Neuroscience Program (INP); although it is also possible to enter the program through a different gateway program, or directly in the first year.
1. Year-long core curriculum courses for a strong foundation in neurobiology.
2. Two quarters of teaching an undergraduate neurobiology lab.
3. Four advanced courses, which relate to the students’ specific research interests.
4. Participation in weekly NeuroBlitz departmental seminars, honing communication skills in science.
5. Attendance at the departmental colloquium series throughout the year.
Graduate Handbook
In their second year, students can begin taking advanced courses. Students are encouraged to satisfactorily complete at least two advanced graduate courses before advancing to candidacy and are required to complete at least four before the dissertation defense. With the consent of the graduate advisor, graduate courses from other departments (see samples at the end of this page) may satisfy part of this requirement if they are not primarily introductory or technically-oriented. Students are encouraged to begin taking advanced courses in their second year and are expected to maintain a GPA of 3.3 or higher.
The list of advanced courses is below – please click on the course title to download a sample syllabus. Please note that several of these courses are taught in alternate years, and so check on the availability in a given year.
In addition, graduate students can take advanced graduate courses offered by other departments. Relevant courses are found below:
MMG 230: Topics in stem cells
Anatomy 230: Neurotrauma
Psych 205A: Computational and Research Methods with MATLAB
PsyBehav P2665: Memory and the Law
MolBiol 215: Integrative Immunol
PhrmSci 272: Drug Discovery